NATCO Pharma posts consolidated total revenue of Rs 2078.9 cr for the year ended on March 31, 2017
In Q4, the company recorded a net revenue of Rs 577.2 crore, on a consolidated basis
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Glenmark gets US FDA nod for ADHD drug
According to IMS Health sales data for the 12 months to April 2017, Strattera capsules achieved annual sales of approximately $1.1…
Sun Pharma recalls 13,000 bottles of chewable cetirizine in US
The reason for the recall is failed tablet/capsule specifications: out of specification results for increased tablet hardness
Sanner acquires Jaco SA
Through the merger Sanner now advances to the global market leader for effervescent packaging
Aurobindo Pharma posts Q4 FY16-17 and FY16-17 financial results
In FY16-17, operating income was up by eight per cent to Rs 15,090 crore
ACG Pharmapack bags SQMP rating from Unilab
Recognised as a 'Certified Supplier' based on a stringent SQMP rating
DuPont Danisco’s Bifidobacterium lactis HN019 gets recorded with Consumer Affairs Agency, Govt…
Bifidobacterium lactis (HN019) improves defecation for those suffering from constipation by adjusting intestinal environment
Role of impurities profiling takes new significance within pharma industry
SCIEX, Beckman Coulter Life Sciences and Express Pharma, organised a seminar on 'Importance of impurities profiling and…
Sun Pharma posts Q4 & FY17 results
In Q4FY17 the consolidated sales / income from operations was at Rs 6,825 crores
Glenmark receives ANDA approval for Olmesartan Medoxomil tabs
The tablets will be manufactured at its Goa facility
Glenmark Pharmaceuticals has been granted final approval by the US FDA for…
Digital A Plus hosts Asia Pacific multichannel marketing expert meeting
The event was attended by delegates from the industry who offered their insights on the theme ‘Reshaping the future of Pharma’
Cipla announces Q4 & FY17 results
Cipla reports Q4 net loss of Rs. 61.8 crores, whereas the revenue was up by 8 per cent
Havas Group acquires Sorento
The addition serves to establish Havas Health & You with a cornerstone health-and-wellness agency in the growing Indian market…
Growth hormone deficiency market to grow steadily : GlobalData
The global growth hormone deficiency (GHD) space, which covers the seven major markets is set to rise to $2.08 billion by 2026
GNH imports Olaratumab to India
It is a monoclonal antibody developed for the treatment of solid tumours soft tissue sarcomas
Clariant announced its financial results for the year ended March 31, 2017
Net Sales for the 12 months ended March 2017 grew by 7.9 per cent, the Board recommends a final dividend of Rs 25/- per share
Sun Pharma received US FDA acceptance of BLA for Tildrakizumab
Tildrakizumab is being evaluated for treatment of moderate-to-severe plaque psoriasis
Novartis India announces results for the quarter and year ended March 31, 2017
During FY 2016-2017 total income stood at ₹ 726.4 crore in comparison to ₹ 770.8 crore recorded in the previous corresponding…
GNH imports Olaratumab to India
It is a monoclonal antibody developed for the treatment of solid tumours soft tissue sarcomas
GNH India, pharmaceutical…
Ozone Ayurvedics launches herbal solution for dry eyes
Enriched with 11 organic herbal actives, ITIS Plus Care Eye Drops brings relief to tired and irritated eyes